enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO)

CUSIP: 29415J106

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, $0.00001 par value
Shares outstanding
20,505,656
Total 13F shares
3,289,256
Share change
-310,935
Total reported value
$17,267,988
Put/Call ratio
6.2%
Price per share
$5.25
Number of holders
25
Value change
-$1,696,568
Number of buys
11
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 29415J106?
CUSIP 29415J106 identifies NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
3.2%
653,870
$3,557,053 31 Mar 2024
13F
PERCEPTIVE ADVISORS LLC
13F
Company
3%
623,315
$3,390,834 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
2.8%
573,955
$3,122,316 31 Mar 2024
13F
Nantahala Capital Management, LLC
13F
Company
2.4%
495,736
$2,696,804 31 Mar 2024
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
1.1%
226,308
$1,231,116 31 Mar 2024
13F
ADAR1 Capital Management, LLC
13F
Company
0.98%
201,728
$1,097,400 31 Mar 2024
13F
Velan Capital Investment Management LP
13F
Company
0.84%
172,235
$936,958 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.67%
137,456
$747,882 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.48%
97,550
$530,672 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.22%
45,561
$247,852 31 Mar 2024
13F
RIA Advisory Group LLC
13F
Company
0.21%
43,666
$237,543 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.2%
40,120
$218,253 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
0.18%
37,491
$203,951 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.17%
35,142
$191,173 31 Mar 2024
13F
Janney Montgomery Scott LLC
13F
Company
0.17%
34,140
$186,000 31 Mar 2024
13F
Laird Norton Wetherby Trust Company, LLC
13F
Company
0.16%
33,000
$179,520 31 Mar 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.12%
25,313
$137,703 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.12%
24,600
$133,824 31 Mar 2024
13F
Fermata Advisors, LLC
13F
Company
0.11%
23,198
$126,197 31 Mar 2024
13F
Squarepoint Ops LLC
13F
Company
0.11%
22,402
$121,867 31 Mar 2024
13F
Quadrature Capital Ltd
13F
Company
0.09%
18,872
$103,230 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.08%
16,411
$89,276 31 Mar 2024
13F
Tamar Securities, LLC
13F
Company
0.07%
13,990
$76,106 31 Mar 2024
13F
HRT FINANCIAL LP
13F
Company
0.07%
13,873
$75,000 31 Mar 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
0.06%
11,350
$61,744 31 Mar 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.03%
6,825
$37,000 31 Mar 2024
13F
UBS Group AG
13F
Company
0.03%
5,558
$30,235 31 Mar 2024
13F
Westside Investment Management, Inc.
13F
Company
0.02%
3,750
$20,400 31 Mar 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.02%
3,487
$18,970 31 Mar 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
2,095
$11,397 31 Mar 2024
13F
CIBC Private Wealth Group LLC
13F
Company
0%
860
$4,532 31 Mar 2024
13F
Craig Glynn
3/4/5
Chief Financial Officer
class O/S missing
75,000
05 Dec 2023

Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q2 2024

As of 30 Jun 2024, enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) was held by 25 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,289,256 shares. The largest 10 holders included KINGDON CAPITAL MANAGEMENT, L.L.C., PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, Nantahala Capital Management, LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), ADAR1 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BlackRock Inc., and Westside Investment Management, Inc.. This page lists 25 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
31
Q2 2024 holders
25
Holder diff
-6
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .